Phase 2 study of inotuzumab ozogamicin in children and young adults with relapsed or refractory cd22+b acute lymphoblastic leukemia
This study is looking at the effects of an experimental drug in pediatric patients with relapsed leukemia.
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005